Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02270021 · ClinicalTrials.gov registry record · NA
Decreasing Over Screening and Treatment of Cervical Precancers in Young Women
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
NCT02270021 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 42 participants.
The verdict
NCT02270021, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
Study Summary
The goal of this study is to prevent over screening and over treatment of young women for cervical precancers, which can result in psychological distress and has been associated with future risk of premature deliveries. Current national guidelines recommend that routine screening be performed at less-frequent intervals and that excisional cervical therapies are discouraged in young women. The objectives of this study are to examine physician- and patient-based interventions designed to decrease over screening and over treatment by increasing adherence to US guidelines for women under 30 years.
Interventions
- OTHER Provider Mobile Application (ProvAPP)
- OTHER ProvAPP + Patient Educational Tool (Tab)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2014-07-24 |
| Est. Completion | 2019-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02270021
The ClinicalTrials.gov registry entry for NCT02270021 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Provider Mobile Application (ProvAPP) is the first listed.
NCT02270021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02270021 about?
NCT02270021 is a clinical study titled "Decreasing Over Screening and Treatment of Cervical Precancers in Young Women". The goal of this study is to prevent over screening and over treatment of young women for cervical precancers, which can result in psychological distress and has been associated with future risk of premature deliveries. Current national guidelines recommend that routine screening be performed at les...
What is the current status of trial NCT02270021?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2014-07-24. Estimated completion is 2019-08-30.
What interventions are being tested in trial NCT02270021?
The interventions under investigation include: Provider Mobile Application (ProvAPP) (OTHER), ProvAPP + Patient Educational Tool (Tab) (OTHER).
Who is sponsoring clinical trial NCT02270021?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.